In our study, the influence on the PI3K/AKT signaling pathway was recognized as key mechanism of XFZYD based on the KEGG pathway enrichment analysis, which provides a vision to fully reveal the mechanisms of XFZYD in the treatment of COPD. Here, AKT1 is linked to chronic obstructive pulmonary disease.